Showing results (231-240 of 296) with videos related to
Sort By:
Pageof 30
Digestive Diseases and Sciences|March 21, 2003
Intensive interferon therapy does not increase virological response rates in African Americans with chronic hepatitis CDickens Theodore, Mitchell L Shiffman, Richard K Sterling, et al.Antimicrobial Agents and Chemotherapy|August 6, 2014
Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfectionCassandra B Jabara, Fengyu Hu, Katie R Mollan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 29, 2015
HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscapeNancy Reau, Michael W Fried, David R Nelson, et al.Hepatology (Baltimore, Md.)|August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirinMichael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 29, 2021
Patient and Physician Satisfaction with Telehealth During the COVID-19 Pandemic: Sports Medicine PerspectiveDavid J Kirby, Jordan W Fried, Daniel B Buchalter, et al.Gastroenterology|August 8, 2006
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1Hari S Conjeevaram, Michael W Fried, Lennox J Jeffers, et al.Alimentary Pharmacology & Therapeutics|October 25, 2021
Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosisHannah P Kim, Michael O Idowu, Andrea R Mospan, et al.American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.Journal of Virology|March 9, 2000
Sequence heterogeneity of TT virus and closely related virusesY E Khudyakov, M E Cong, B Nichols, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 26, 2011
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis CSarah J Schrieber, Roy L Hawke, Zhiming Wen, et al.Pageof 30